Страница результатов 2 - Сектор: Здравоохранение Отрасль: Производители лекарств-Общие Котировки акций и цены - фондовый рынок
Список всех акций публичных компаний с указанием цен, рыночной капитализации, PE и EPS
Все страны
- {{country.name}}
- Все страны
- Соединенные Штаты (50)
- Аргентина (13)
- Австралия (1)
- Австрия (13)
- Бразилия (14)
- Канада (2)
- Чили (4)
- Китай (22)
- Финляндия (2)
- Франция (3)
- Германия (58)
- Гонконг (4)
- Венгрия (1)
- Индия (20)
- Индонезия (1)
- Италия (5)
- Япония (9)
- Мексика (14)
- Сингапур (1)
- Южная Корея (3)
- Испания (1)
- Швеция (3)
- Швейцария (6)
- Тайвань (1)
- Турция (1)
- Великобритания (20)
Все биржи
- {{item.name}}
- Все биржи
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
Здравоохранение (279)
- {{item.name}}
- Все секторы
- Здравоохранение (279)
Производители лекарств-Общие (279)
- {{item.name}}
- Все отрасли
- Биотехнологии (2611)
- Производители лекарств-Общие (279)
- Производители лекарств-Специализированные и дженерики (1705)
- Планы здравоохранения (57)
- Медицинские учреждения (553)
- Розничные продавцы фармацевтической продукции (155)
- Информационные службы здравоохранения (419)
- Медицинские приборы (913)
- Медицинские инструменты и принадлежности (501)
- Диагностика и исследования (427)
- Медицинская дистрибуция (138)
| Название Название | Цена Цена |
24h% 7d chart 24h% & 7d |
Рын. Кап. Капитализация | Объём Объём | 24ч мин | 24ч макс | Капитализация | Цена/доход | Прибыль на акцию |
|---|
| Название Название | Цена Цена |
24h% 7d chart 24h% & 7d |
Рын. Кап. Капитализация | Объём Объём | 24ч мин | 24ч макс | Капитализация | Цена/доход | Прибыль на акцию | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Eli Lilly and Company LLY.F | $672.3 734.91 USD |
-5.84
|
$603.72B 659.95B USD | $1.26K 1.38K USD | $672.3 734.91 USD | $714 780.5 USD | $603.72B 659.95B USD | 63.30 | $10.62 11.61 USD | |
| Johnson & Johnson JNJ.BA | $13,650 16.13 USD |
-2.85
|
$396.76T 468.98B USD | $36.72K 43.4 USD | $13,600 16.08 USD | $14,150 16.73 USD | $396.76T 468.98B USD | 10.97 | $1.24K 1.47 USD | |
| Johnson & Johnson JNJ.MX | $3,255 192.74 USD |
+1.97
|
$7.84T 464.46B USD | $3.16K 186.93 USD | $3,254.99 192.74 USD | $3,255.64 192.77 USD | $7.84T 464.46B USD | 28.16 | $115.55 6.84 USD | |
| Johnson & Johnson JNJB34.SA | $59.67 12.09 USD |
-0.58
|
$2.16T 437.17B USD | $26.23K 5.32K USD | $59.67 12.09 USD | $61.52 12.47 USD | $2.16T 437.17B USD | 27.49 | $2.17 0.44 USD | |
| AbbVie Inc. ABBV.BA | $24,975 29.52 USD |
-6.02
|
$355.33T 420.02B USD | $1.62K 1.92 USD | $24,925 29.46 USD | $26,275 31.06 USD | $355.33T 420.02B USD | 9.72 | $2.57K 3.03 USD | |
| AbbVie Inc. ABBV.MX | $3,912 231.64 USD |
-2.88
|
$6.92T 409.76B USD | $3.36K 199.01 USD | $3,912 231.64 USD | $3,912 231.64 USD | $6.92T 409.76B USD | 81.96 | $47.73 2.83 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV34.SA | $67.69 13.72 USD |
-4.24
|
$1.92T 388.32B USD | $3.21K 651.22 USD | $67.69 13.72 USD | $71.61 14.51 USD | $1.92T 388.32B USD | 80.58 | $0.84 0.17 USD | |
| Johnson & Johnson JNJ.VI | $141.8 155.01 USD |
-1.88
|
$341.72B 373.54B USD | $558 609.97 USD | $141.8 155.01 USD | $144.78 158.26 USD | $341.72B 373.54B USD | 26.75 | $5.3 5.79 USD | |
| Johnson & Johnson JNJ.F | $140.68 153.78 USD |
-2.72
|
$339.02B 370.59B USD | $693 757.54 USD | $140.68 153.78 USD | $145.24 158.77 USD | $339.02B 370.59B USD | 26.79 | $5.25 5.74 USD | |
| AbbVie Inc. ABBV.VI | $176.74 193.2 USD |
-4.06
|
$312.65B 341.77B USD | $0 0 USD | $176.74 193.2 USD | $181.5 198.4 USD | $312.65B 341.77B USD | 80.70 | $2.19 2.39 USD | |
| AbbVie Inc. 4AB.DE | $176.56 193 USD |
-4.38
|
$312.33B 341.42B USD | $2.46K 2.69K USD | $176.56 193 USD | $182.72 199.74 USD | $312.33B 341.42B USD | 81.36 | $2.17 2.37 USD | |
| AbbVie Inc. 4AB.F | $172.98 189.09 USD |
-6.18
|
$306B 334.5B USD | $252 275.47 USD | $172.98 189.09 USD | $182.48 199.48 USD | $306B 334.5B USD | 80.08 | $2.16 2.36 USD | |
| Roche Holding AG ROGN.MX | $6,280.1 371.86 USD |
-6.13
|
$4.87T 288.48B USD | $108 6.39 USD | $6,280.1 371.86 USD | $6,280.1 371.86 USD | $4.87T 288.48B USD | 26.24 | $239.27 14.17 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| AstraZeneca PLC AZN.BA | $45,750 54.08 USD |
-6.15
|
$235.58T 278.47B USD | $1.51K 1.78 USD | $45,725 54.05 USD | $47,200 55.79 USD | $235.58T 278.47B USD | 9.46 | $4.84K 5.72 USD | |
| AstraZeneca PLC AZNN.MX | $1,490 88.23 USD |
0
|
$4.62T 273.53B USD | $1 0.06 USD | $1,490 88.23 USD | $1,490 88.23 USD | $4.62T 273.53B USD | 33.22 | $44.85 2.66 USD | |
| Novartis AG NVS.BA | $35,425 41.87 USD |
-4.64
|
$227.25T 268.62B USD | $1.98K 2.34 USD | $35,425 41.87 USD | $35,975 42.52 USD | $227.25T 268.62B USD | 2.80 | $12.61K 14.91 USD | |
| Novartis AG NVSN.MX | $2,235 132.34 USD |
0
|
$4.41T 261.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.41T 261.38B USD | 19.08 | $117.11 6.93 USD | |
| Merck & Co., Inc. MRK.BA | $21,800 25.77 USD |
-4.6
|
$221.11T 261.36B USD | $5.08K 6 USD | $21,625 25.56 USD | $22,500 26.6 USD | $221.11T 261.36B USD | 0.30 | $72.42K 85.6 USD | |
| Merck & Co., Inc. MRCK34.SA | $62 12.57 USD |
+1.44
|
$1.25T 253.95B USD | $13.96K 2.83K USD | $59.06 11.97 USD | $62 12.57 USD | $1.25T 253.95B USD | 13.05 | $4.75 0.96 USD | |
| AstraZeneca PLC A1ZN34.SA | $67.12 13.6 USD |
-3.72
|
$1.25T 253.07B USD | $129 26.15 USD | $66.89 13.56 USD | $69.71 14.13 USD | $1.25T 253.07B USD | 31.81 | $2.11 0.43 USD | |
| Merck & Co., Inc. MRK.MX | $1,683 99.65 USD |
-2.26
|
$4.25T 251.73B USD | $81 4.8 USD | $1,658 98.17 USD | $1,725 102.14 USD | $4.25T 251.73B USD | 12.51 | $134.47 7.96 USD | |
| Novartis AG N1VS34.SA | $62.73 12.71 USD |
0
|
$1.24T 251.12B USD | $0 0 USD | $62.73 12.71 USD | $62.73 12.71 USD | $1.24T 251.12B USD | 18.95 | $3.31 0.67 USD | |
| Roche Holding AG RHHBF | $336.92 — |
+3.67
|
$244.3B — | $50 — | $325 — | $330.5 — | $244.3B — | 28.64 | $11.76 — | |
| Roche Holding AG RHHVF | $302 — |
-0.82
|
$244.3B — | $288 — | $304 — | $312 — | $244.3B — | 25.70 | $11.75 — | |
| Merck & Co., Inc. MRK.SN | $96.42 — |
-25.14
|
$243.56B — | $0 — | $96.42 — | $96.42 — | $243.56B — | 14.30 | $6.74 — | |
| Roche Holding AG RHO6.F | $34.57 37.79 USD |
-5.03
|
$221.22B 241.83B USD | $72 78.71 USD | $34.5 37.71 USD | $35.8 39.13 USD | $221.22B 241.83B USD | 25.41 | $1.36 1.49 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| AstraZeneca PLC ZEG.F | $126.4 138.17 USD |
-7.94
|
$211.25B 230.92B USD | $891 973.98 USD | $126.4 138.17 USD | $134.15 146.64 USD | $211.25B 230.92B USD | 31.05 | $4.07 4.45 USD | |
| AstraZeneca PLC ZEGA.F | $62 67.77 USD |
-6.77
|
$211.25B 230.92B USD | $100 109.31 USD | $62 67.77 USD | $67 73.24 USD | $211.25B 230.92B USD | 30.39 | $2.04 2.23 USD | |
| AstraZeneca PLC AZNCF | $136.64 — |
-1.02
|
$230.37B — | $100 — | $138.05 — | $138.05 — | $230.37B — | 30.36 | $4.5 — | |
| Novartis AG NOTA.F | $97.8 106.91 USD |
-3.65
|
$193.16B 211.15B USD | $20 21.86 USD | $97.8 106.91 USD | $99 108.22 USD | $193.16B 211.15B USD | 18.38 | $5.32 5.82 USD | |
| Merck & Co., Inc. MRK.VI | $75.7 82.75 USD |
-4.3
|
$191.22B 209.03B USD | $229 250.33 USD | $75.7 82.75 USD | $78.1 85.37 USD | $191.22B 209.03B USD | 12.24 | $6.18 6.76 USD | |
| Merck & Co., Inc. 6MK.F | $74.3 81.22 USD |
-5.35
|
$187.68B 205.16B USD | $1.6K 1.75K USD | $74.3 81.22 USD | $78.1 85.37 USD | $187.68B 205.16B USD | 12.18 | $6.1 6.67 USD | |
| Amgen Inc. AMGN.MX | $6,430 380.73 USD |
0
|
$3.45T 204.53B USD | $1 0.06 USD | $6,430 380.73 USD | $6,430 380.73 USD | $3.45T 204.53B USD | 42.73 | $150.46 8.91 USD | |
| Amgen Inc. AMGN.BA | $13,075 15.46 USD |
-3.68
|
$169.91T 200.84B USD | $1.81K 2.14 USD | $13,075 15.46 USD | $13,700 16.19 USD | $169.91T 200.84B USD | 0.32 | $40.61K 48.01 USD | |
| Amgen Inc. AMGN34.SA | $61.84 12.53 USD |
+0.24
|
$930.18B 188.53B USD | $10 2.03 USD | $61.69 12.5 USD | $62.27 12.62 USD | $930.18B 188.53B USD | 40.68 | $1.52 0.31 USD | |
| Gilead Sciences, Inc. GILD.BA | $35,775 42.29 USD |
-3.31
|
$143.65T 169.8B USD | $1.09K 1.29 USD | $35,775 42.29 USD | $37,775 44.65 USD | $143.65T 169.8B USD | 87.71 | $407.84 0.48 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,259.6 133.8 USD |
-0.81
|
$2.82T 166.79B USD | $40 2.37 USD | $2,259.6 133.8 USD | $2,259.6 133.8 USD | $2.82T 166.79B USD | 294.21 | $7.68 0.45 USD | |
| Pfizer Inc. PFE.BA | $7,690 9.09 USD |
-4.23
|
$139.97T 165.44B USD | $25.61K 30.27 USD | $7,660 9.05 USD | $7,900 9.34 USD | $139.97T 165.44B USD | 2.53 | $3.03K 3.58 USD | |
| Amgen Inc. AMG.F | $278 303.89 USD |
+1.46
|
$149.34B 163.25B USD | $190 207.7 USD | $276.5 302.25 USD | $282.5 308.81 USD | $149.34B 163.25B USD | 40.64 | $6.84 7.48 USD | |
| Amgen Inc. AMG.DE | $275.3 300.94 USD |
-1.1
|
$147.89B 161.67B USD | $886 968.52 USD | $274.8 300.39 USD | $284.05 310.51 USD | $147.89B 161.67B USD | 40.18 | $6.85 7.49 USD | |
| Amgen Inc. AMGN.VI | $275.15 300.78 USD |
-1.11
|
$147.81B 161.58B USD | $145 158.5 USD | $275.15 300.78 USD | $281.6 307.83 USD | $147.81B 161.58B USD | 39.70 | $6.93 7.58 USD | |
| Gilead Sciences, Inc. GILD34.SA | $318.72 64.6 USD |
-0.45
|
$794.65B 161.06B USD | $185 37.5 USD | $317.6 64.37 USD | $323.65 65.6 USD | $794.65B 161.06B USD | 295.11 | $1.08 0.22 USD | |
| Pfizer Inc. PFE.MX | $470.86 27.88 USD |
-3.35
|
$2.67T 158.12B USD | $1.17K 69.22 USD | $470.5 27.86 USD | $485 28.72 USD | $2.67T 158.12B USD | 16.75 | $28.11 1.66 USD | |
| Pfizer Inc. PFIZ34.SA | $33.63 6.82 USD |
-1.29
|
$762.92B 154.63B USD | $7.26K 1.47K USD | $33.55 6.8 USD | $34.59 7.01 USD | $762.92B 154.63B USD | 16.98 | $1.98 0.4 USD | |
| Pfizer Inc. PFE.SN | $26.06 — |
0
|
$147.8B — | $0 — | $26.06 — | $26.06 — | $147.8B — | 18.48 | $1.41 — | |
| Bristol-Myers Squibb Company BMY.BA | $24,675 29.17 USD |
-1.7
|
$120.89T 142.9B USD | $600 0.71 USD | $24,375 28.81 USD | $25,100 29.67 USD | $120.89T 142.9B USD | 0 | -$4,737 -5.6 USD | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$142.75B — | $0 — | $95.78 — | $95.78 — | $142.75B — | 252.05 | $0.38 — | |
| Gilead Sciences, Inc. GILD.VI | $101.48 110.93 USD |
-1.44
|
$126.51B 138.29B USD | $204 223 USD | $100.3 109.64 USD | $102.54 112.09 USD | $126.51B 138.29B USD | 289.94 | $0.35 0.38 USD | |
| Gilead Sciences, Inc. GIS.DE | $101.42 110.87 USD |
-1.74
|
$126.43B 138.21B USD | $5.35K 5.84K USD | $99.79 109.08 USD | $103.88 113.55 USD | $126.43B 138.21B USD | 298.29 | $0.34 0.37 USD | |
| Bristol-Myers Squibb Company BMY.MX | $1,128 66.79 USD |
-7.01
|
$2.3T 135.9B USD | $212 12.55 USD | $1,128 66.79 USD | $1,128 66.79 USD | $2.3T 135.9B USD | 0 | -$87.98 -5.2 USD | |
| Gilead Sciences, Inc. GIS.F | $99 108.22 USD |
-3.96
|
$123.42B 134.91B USD | $702 767.38 USD | $99 108.22 USD | $102 111.5 USD | $123.42B 134.91B USD | 282.85 | $0.35 0.38 USD | |
| Sanofi SNW2.F | $49.6 54.22 USD |
-1.78
|
$121.77B 133.12B USD | $100 109.31 USD | $49.2 53.78 USD | $49.6 54.22 USD | $121.77B 133.12B USD | 22.54 | $2.2 2.4 USD | |
| Sanofi SANO.VI | $97.72 106.82 USD |
-1.82
|
$121.77B 133.12B USD | $182 198.95 USD | $96.79 105.8 USD | $98.4 107.56 USD | $121.77B 133.12B USD | 22.25 | $4.39 4.8 USD | |
| Sanofi SNW.F | $93.5 102.21 USD |
-6.23
|
$121.77B 133.11B USD | $443 484.26 USD | $93 101.66 USD | $99.72 109.01 USD | $121.77B 133.11B USD | 21.29 | $4.39 4.8 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $322.11 65.29 USD |
-1.46
|
$655.42B 132.84B USD | $66 13.38 USD | $319 64.66 USD | $326.89 66.26 USD | $655.42B 132.84B USD | 0 | -$24.82 -5.03 USD | |
| Sanofi SNYNF | $103.98 — |
-5.34
|
$132.79B — | $100 — | $103.98 — | $103.98 — | $132.79B — | 21.43 | $4.85 — | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Pfizer Inc. PFE.VI | $21.32 23.31 USD |
-4.86
|
$120.92B 132.18B USD | $2.68K 2.93K USD | $20.9 22.85 USD | $22.08 24.13 USD | $120.92B 132.18B USD | 16.52 | $1.29 1.41 USD | |
| Pfizer Inc. PFEB.F | $6.9 7.54 USD |
-1.43
|
$117.97B 128.96B USD | $500 546.57 USD | $6.9 7.54 USD | $6.9 7.54 USD | $117.97B 128.96B USD | 16.04 | $0.43 0.47 USD | |
| GSK plc GSK.BA | $12,175 14.39 USD |
-5.44
|
$98.9T 116.9B USD | $497 0.59 USD | $12,100 14.3 USD | $12,500 14.78 USD | $98.9T 116.9B USD | 27.85 | $437.08 0.52 USD | |
| Bristol-Myers Squibb Company BRM.DE | $51.09 55.85 USD |
-5.02
|
$103.96B 113.64B USD | $7.47K 8.17K USD | $50.6 55.31 USD | $52.19 57.05 USD | $103.96B 113.64B USD | 0 | -$4 -4.3 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $51.01 55.76 USD |
-6.88
|
$103.79B 113.46B USD | $0 0 USD | $51.01 55.76 USD | $51.79 56.61 USD | $103.79B 113.46B USD | 0 | -$4.05 -4.4 USD | |
| Bristol-Myers Squibb Company BRM.F | $50.42 55.12 USD |
-5.95
|
$102.59B 112.15B USD | $1.83K 2K USD | $50.05 54.71 USD | $51.52 56.32 USD | $102.59B 112.15B USD | 0 | -$3.99 -4.3 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $811 48.02 USD |
0
|
$1.65T 97.52B USD | $0 0 USD | $811 48.02 USD | $811 48.02 USD | $1.65T 97.52B USD | 25.00 | $32.44 1.92 USD | |
| GSK plc G1SK34.SA | $43.24 8.76 USD |
0
|
$439.04B 88.99B USD | $0 0 USD | $43.24 8.76 USD | $43.24 8.76 USD | $439.04B 88.99B USD | 23.62 | $1.83 0.37 USD | |
| GSK GLAXF | $18.38 — |
0
|
$77.65B — | $107 — | $20.12 — | $20.16 — | $77.65B — | 22.69 | $0.81 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $39.36 43.03 USD |
0
|
$67.79B 74.1B USD | $33 36.07 USD | $39.36 43.03 USD | $40.24 43.99 USD | $67.79B 74.1B USD | 26.95 | $1.46 1.6 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $22.33 24.41 USD |
+0.04
|
$41.89B 45.8B USD | $2K 2.19K USD | $22.33 24.41 USD | $22.33 24.41 USD | $41.89B 45.8B USD | 27.91 | $0.8 0.87 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $46.8 51.16 USD |
0
|
$25.29B 27.64B USD | $420 459.12 USD | $46.8 51.16 USD | $46.8 51.16 USD | $25.29B 27.64B USD | 11.93 | $3.92 4.29 USD | |
| Biogen Inc. BIIB.MX | $2,854 168.99 USD |
0
|
$417.75B 24.74B USD | $0 0 USD | $2,854 168.99 USD | $2,854 168.99 USD | $417.75B 24.74B USD | 12.80 | $222.9 13.2 USD | |
| Biogen Inc. BIIB.BA | $12,725 15.04 USD |
-3.78
|
$19.34T 22.86B USD | $1.43K 1.69 USD | $12,650 14.95 USD | $13,050 15.43 USD | $19.34T 22.86B USD | 1.05 | $12.01K 14.2 USD | |
| Bayer Aktiengesellschaft BAYER.BD | $8,166 22.58 USD |
-6.14
|
$8.02T 22.19B USD | $310 0.86 USD | $8,160 22.57 USD | $8,600 23.79 USD | $8.02T 22.19B USD | 0 | -$1,043.6 -2.8 USD | |
| Biogen Inc. BIIB34.SA | $122.52 24.83 USD |
0
|
$108.04B 21.9B USD | $0 0 USD | $122.52 24.83 USD | $122.52 24.83 USD | $108.04B 21.9B USD | 11.72 | $10.45 2.12 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $20.07 21.94 USD |
-5.66
|
$19.74B 21.58B USD | $3.9K 4.26K USD | $19.87 21.72 USD | $21.18 23.15 USD | $19.74B 21.58B USD | 0 | -$2.6 -2.8 USD | |
| Bayer Aktiengesellschaft BAYA.F | $4.9 5.36 USD |
-5.77
|
$19.74B 21.58B USD | $35 38.26 USD | $4.9 5.36 USD | $5.1 5.57 USD | $19.74B 21.58B USD | 0 | -$0.65 -0.7 USD | |
| Biogen Inc. BIIB.VI | $114.45 125.11 USD |
-3.13
|
$16.75B 18.31B USD | $0 0 USD | $114.45 125.11 USD | $117.65 128.61 USD | $16.75B 18.31B USD | 11.16 | $10.25 11.2 USD | |
| Biogen Inc. IDP.DE | $114.05 124.67 USD |
-3.71
|
$16.69B 18.25B USD | $226 247.05 USD | $114.05 124.67 USD | $118.2 129.21 USD | $16.69B 18.25B USD | 11.25 | $10.13 11.07 USD | |
| Biogen Inc. IDP.F | $113.75 124.34 USD |
-2.4
|
$16.65B 18.2B USD | $38 41.54 USD | $113.75 124.34 USD | $117.35 128.28 USD | $16.65B 18.2B USD | 11.24 | $10.12 11.06 USD | |
| Astellas Pharma ALPMF | $9.45 — |
0
|
$17.01B — | $1K — | $9.45 — | $9.45 — | $17.01B — | 0 | -$0.22 — | |
| Astellas Pharma Inc. YPH.F | $8.02 8.77 USD |
-1.52
|
$15.41B 16.84B USD | $27 29.51 USD | $8.02 8.77 USD | $8.47 9.26 USD | $15.41B 16.84B USD | 0 | -$0.2 -0.2 USD | |
| Astellas Pharma Inc. YPHA.F | $8.35 9.13 USD |
+3.73
|
$15.41B 16.84B USD | $0 0 USD | $8.35 9.13 USD | $8.35 9.13 USD | $15.41B 16.84B USD | 0 | -$0.2 -0.2 USD | |
| Cipla Limited CIPLA.BO | $1,415.55 17.13 USD |
-5.32
|
$1.14T 13.83B USD | $52.09K 630.17 USD | $1,390.35 16.82 USD | $1,499.25 18.14 USD | $1.14T 13.83B USD | 22.93 | $61.72 0.75 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $50.75 55.48 USD |
-0.68
|
$10.58B 11.56B USD | $40 43.73 USD | $50.75 55.48 USD | $51.4 56.19 USD | $10.58B 11.56B USD | 25.50 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $51.05 55.8 USD |
-0.87
|
$10.58B 11.56B USD | $0 0 USD | $50.25 54.93 USD | $51.7 56.52 USD | $10.58B 11.56B USD | 25.65 | $1.99 2.18 USD | |
| Orion Oyj ORINY | $31.1 — |
0
|
$8.18B — | $248 — | $31.06 — | $31.06 — | $8.18B — | 24.29 | $1.28 — | |
| CSPC Pharmaceutical CHJTF | $0.56 — |
0
|
$8.11B — | $11K — | $0.93 — | $0.9499 — | $8.11B — | 11.19 | $0.05 — | |
| Orion Oyj OFK.F | $51.68 56.49 USD |
-6.21
|
$7.4B 8.09B USD | $25 27.33 USD | $51.68 56.49 USD | $54.28 59.34 USD | $7.4B 8.09B USD | 21.99 | $2.35 2.57 USD | |
| Orion Oyj OFK0.F | $26.8 29.3 USD |
-0.74
|
$7.4B 8.09B USD | $0 0 USD | $26.8 29.3 USD | $26.8 29.3 USD | $7.4B 8.09B USD | 22.90 | $1.17 1.28 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $2.36 2.58 USD |
+2.61
|
$7.37B 8.05B USD | $750 819.85 USD | $2.36 2.58 USD | $2.36 2.58 USD | $7.37B 8.05B USD | 13.11 | $0.18 0.2 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.63 0.69 USD |
-0.41
|
$7.37B 8.05B USD | $23K 25.14K USD | $0.5999 0.66 USD | $0.63 0.69 USD | $7.37B 8.05B USD | 12.54 | $0.05 0.05 USD | |
| Kyowa Kirin KYKOF | $14.75 — |
0
|
$7.89B — | $316 — | $14.75 — | $14.75 — | $7.89B — | 19.40 | $0.76 — | |
| Kyowa Kirin Co., Ltd. KY4.F | $13 14.21 USD |
+4
|
$7.14B 7.81B USD | $254 277.66 USD | $13 14.21 USD | $13.2 14.43 USD | $7.14B 7.81B USD | 18.57 | $0.7 0.77 USD | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
| Abbott India Limited ABBOTINDIA.NS | $29,077.4 351.79 USD |
-2.78
|
$617.87B 7.48B USD | $9.17K 110.89 USD | $28,829.15 348.78 USD | $30,090.55 364.05 USD | $617.87B 7.48B USD | 46.29 | $628.07 7.6 USD | |
| Abbott India Limited ABBOTINDIA.BO | $29,049.1 351.45 USD |
-2.98
|
$617.27B 7.47B USD | $588 7.11 USD | $28,822.15 348.7 USD | $29,998.75 362.93 USD | $617.27B 7.47B USD | 46.29 | $627.46 7.59 USD | |
|
Нет избранных акций
У вас еще нет любимых акций, пожалуйста, добавьте их в избранное, чтобы увидеть их здесь |
||||||||||
- {{ link.label }} {{link}}